Compare Mesoblast Limited (MESO) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Mesoblast Limited trades at $16.28 (market cap $2.17B), while Direxion Daily Semiconductor Bear 3X Shares trades at $46.92. Which is the better fit depends on your goals.
| MESO | SOXS | |
|---|---|---|
Market Cap | $2.17B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $20.96 | $1.61K |
52-Week Low | $12.88 | $32.50 |
Enterprise Value | $2.17B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MESO trades at $16.63, down 3.98% on the day, with a bullish technical outlook supported by moving averages. The company shows strong revenue growth with Ryoncil generating $115 million in annual revenue, though it remains unprofitable with a net loss of $102 million. Recent developments include positive Phase 3 trial progress and FDA BLA filings for new treatments.
Investment outlook balances promising pipeline progress against significant financial losses. The stock offers growth potential through commercial expansion but carries substantial risk from continued cash burn and regulatory hurdles. Analyst consensus leans bullish with 45% buy ratings, reflecting optimism about the company's transition to commercial-stage operations.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $53.99, down 1.64% today, reflecting its inverse leveraged exposure to semiconductor stocks. Technical indicators show a bullish moving average signal but bearish oscillators with RSI levels above 96 suggesting extreme overbought conditions. Recent news highlights SOXS surging during semiconductor sell-offs, with a 1:10 stock split scheduled for July 26, 2026. The fund is designed for short-term tactical trades amid sector volatility.
The outlook for SOXS remains highly speculative, offering potential gains during semiconductor downturns but carrying significant decay and volatility risks. Investors should be cautious as the ETF is not suitable for long-term holdings due to its daily reset structure and inverse leverage, which can lead to substantial losses in rising markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
